MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹5,315 Cr | ₹5,358 Cr | ₹4,702 Cr | ₹2,417 Cr | ₹2,203 Cr |
What is the latest Total Non-Current Assets ratio of MANKIND PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹5,315 Cr |
Mar2023 | ₹5,358 Cr |
Mar2022 | ₹4,702 Cr |
Mar2021 | ₹2,417 Cr |
Mar2020 | ₹2,203 Cr |
How is Total Non-Current Assets of MANKIND PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹5,315 Cr | -0.81 | |
Mar2023 | ₹5,358 Cr | 13.96 | |
Mar2022 | ₹4,702 Cr | 94.52 | |
Mar2021 | ₹2,417 Cr | 9.71 | |
Mar2020 | ₹2,203 Cr | - |
Compare Total Non-Current Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹98,505.3 Cr | 1.4% | -6.4% | 11.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.4% |
-6.4% |
11.8% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses